Reviva Pharmaceuticals Holdings, Inc. RVPH

Healthcare Biotechnology

Reviva Pharmaceuticals Holdings, Inc. is a clinical-stage biopharmaceutical company. The Company discovers, develops, and seeks to commercialize therapeutics for diseases representing unmet medical needs. The Company’s pipeline focuses on the central nervous system and respiratory and metabolic diseases. Its pipeline includes two drug candidates, RP5063 (brilaroxazine) and RP1208. Its lead drug candidate, brilaroxazine, is in clinical development and is to treat multiple neuropsychiatric indications. These include schizophrenia, bipolar disorder (BD), major depressive disorder (MDD), attention-deficit/hyperactivity disorder (ADHD), behavioral and psychotic symptoms of dementia or Alzheimer’s disease (BPSD), and Parkinson’s disease psychosis. Brilaroxazine is also ready for clinical development for two respiratory indications, including pulmonary arterial hypertension (PAH) and idiopathic pulmonary fibrosis (IPF). Its RP1208 drug candidate is a triple reuptake inhibitor (TRI).

NDAQ:RVPH - Post by User

Reviva Pharmaceuticals Holdings, Inc. > On watch.... News Release this a.m

<< Previous

Bullboard Posts

Next >>

Comment by Iseneschalon Apr 26, 2021 11:14am

33 Views

Post# 33066520

RE:RE:RE:On watch.... News Release this a.m

Iseneschal wrote:

Iseneschal wrote:

Iseneschal wrote: Tough one here..... So far all I've seen is a "Strike 1"............

It got close to "Strike 2".....but held.

Volume has been declining since the double top at the high of day.

Watching closely for an entry....maybe.

Cheers !

Careful now..... possible "Strike 2"......just sayin......if it goes sub $6.00

Volume is still declining but is still holding the $6.00 line